Skip to main content
OpenTrials

Clinical trial condition

rLP2086

Explore clinical trials studying rLP2086. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

rLP2086 trial results

Completed

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

NCT01323270

Conditions
Meningitis, Meningococcal Vaccine, N Meningitidis Serogroup B, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Helsinki South Vaccine Research Clinic Helsinki, Finland
  • Ita-Helsinki Vaccine Research Clinic Helsinki, Finland
  • Järvenpää Vaccine Research Clinic Jarvenpaa, Finland
View all 36 locations
View Trial Details

Related conditions